Medicine and Dentistry
Cerebral Hemorrhage
100%
Bleeding
49%
Blood Clot Lysis
38%
Alteplase
38%
Evacuation
31%
Minimally Invasive Surgery
29%
Clinical Trial
23%
COVID-19
21%
Hematoma
19%
Cavernous Hemangioma
17%
Infection
16%
Modified Rankin Scale
16%
Outpatient
15%
Placebo
15%
Randomized Controlled Trial
14%
Odds Ratio
12%
Convalescence
12%
Quantitative Susceptibility Mapping
11%
Computer Assisted Tomography
11%
Biological Marker
11%
Hypothermia
10%
Adverse Event
9%
Aneurysm Surgery
9%
Apoplexy
8%
Cardiovascular System
7%
Congenital Malformation
7%
Brain Artery Aneurysm
7%
Medical Care
6%
Functional Status
5%
Surgeon
5%
Subarachnoid Hemorrhage
5%
Systolic Blood Pressure
5%
Observational Study
5%
Thrombolytic Drug
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Keyphrases
Intraventricular Hemorrhage
41%
Intracerebral Hemorrhage
24%
Convalescent Plasma
19%
Clot Lysis
17%
Symptomatic Hemorrhage
17%
Trial Readiness
15%
Spontaneous Intracerebral Hemorrhage
14%
COVID-19
14%
Modified Rankin Scale
14%
Minimally Invasive Surgery
11%
Alteplase
11%
Evacuation
11%
MISTIE
11%
External Ventricular Drain
10%
Thrombolysis
10%
Survivors
9%
Placebo-controlled
8%
COVID-19 Convalescent Plasma
8%
Hemorrhage Volume
8%
Clinical Trials
8%
Phase II Trial
8%
Bleeding
8%
Adjusted Odds Ratio
7%
Quantitative Susceptibility Mapping
7%
Cavernous Malformation
7%
Cavernous Angioma
7%
Cerebral Aneurysm Surgery
7%
Clinical Outcomes
7%
Adverse Events
6%
Transfusion
6%
Hospitalization
6%
Confidence Interval
5%
Patient Characteristics
5%
Randomized Trial
5%
Rebleeding
5%
